TD ASSET MANAGEMENT INC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 183 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$658,000
-40.5%
15,300
-32.0%
0.00%
-50.0%
Q3 2018$1,106,000
+26.8%
22,500
-17.3%
0.00%
+100.0%
Q2 2018$872,000
-3.8%
27,200
-6.5%
0.00%0.0%
Q1 2018$906,000
-27.3%
29,100
+6.6%
0.00%
-50.0%
Q4 2017$1,246,000
+28.6%
27,300
+5.8%
0.00%
+100.0%
Q3 2017$969,000
-33.5%
25,800
-15.6%
0.00%
-50.0%
Q2 2017$1,458,000
-11.9%
30,563
-15.7%
0.00%
-33.3%
Q1 2017$1,654,000
+21.7%
36,263
-13.8%
0.00%
+50.0%
Q4 2016$1,359,000
-36.1%
42,063
-32.4%
0.00%
-50.0%
Q3 2016$2,128,000
-17.2%
62,200
-18.4%
0.00%
-20.0%
Q2 2016$2,570,000
-32.6%
76,200
+5.8%
0.01%
-28.6%
Q1 2016$3,815,000
-33.5%
72,000
-3.6%
0.01%
-36.4%
Q4 2015$5,736,000
+90.1%
74,700
+1.8%
0.01%
+83.3%
Q3 2015$3,017,000
-40.2%
73,400
+2.9%
0.01%
-33.3%
Q2 2015$5,042,000
-29.4%
71,300
-11.3%
0.01%
-30.8%
Q1 2015$7,144,000
+10.5%
80,400
+10.3%
0.01%
+18.2%
Q4 2014$6,463,000
-22.1%
72,900
-14.8%
0.01%
-21.4%
Q3 2014$8,296,000
+14.0%
85,600
+8.1%
0.01%
+16.7%
Q2 2014$7,275,000
+27.9%
79,200
-2.6%
0.01%
+20.0%
Q1 2014$5,690,000
+29.7%
81,300
+6.6%
0.01%
+25.0%
Q4 2013$4,386,000
+17.1%
76,300
-2.1%
0.01%
+14.3%
Q3 2013$3,746,000
+58.7%
77,900
-4.3%
0.01%
+40.0%
Q2 2013$2,361,00081,4000.01%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,799,916$121,768,0008.62%
Tamarack Advisers, LP 625,000$27,044,0008.22%
NEXTHERA CAPITAL LP 149,086$6,484,0005.40%
Spyglass Capital Management LLC 379,609$16,509,0005.22%
Gagnon Advisors, LLC 107,412$4,671,0002.67%
GAGNON SECURITIES LLC 278,613$12,117,0002.61%
Asymmetry Capital Management, L.P. 84,735$3,685,0002.00%
Rock Springs Capital Management LP 1,250,000$54,363,0001.97%
Lisanti Capital Growth, LLC 118,620$5,159,0001.68%
Elk Creek Partners, LLC 500,069$21,748,0001.62%
View complete list of PACIRA PHARMACEUTICALS INC shareholders